Type to search

BrainVectis, a Subsidiary of AskBio, Receives Clearance to Conduct Phase I/II Clinical Trial in France for Its Novel Gene Therapy for Early-stage Huntington’s Disease | Pharmtech Focus
AskBio Announces IND for LION-101, a Novel Investigational AAV Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy | Pharmtech Focus